Precision BioSciences, Inc

(NASDAQ:DTIL)

Latest On Precision BioSciences, Inc (DTIL):

Date/Time Type Description Signal Details
2023-05-31 19:19 ESTNewsPrecision CAR T lymphoma therapy offers good complete responseN/A
2023-05-09 12:23 ESTNewsPrecision BioSciences GAAP EPS of -$0.23 in-line, revenue of $8.78M beats by $2.31MN/A
2023-05-08 23:08 ESTNewsPrecision BioSciences Q1 2023 Earnings PreviewN/A
2023-04-18 09:39 ESTNewsPrecision Biosciences says it has cash to run through Q1 2025N/A
2023-04-13 19:53 ESTNewsPrecision BioSciences to get US patent linked to gene-editing technologyN/A
2023-03-22 10:29 ESTNewsiECURE's therapy GTP-506 for urea cycle disorder gets orphan drug status in EUN/A
2023-03-09 15:47 ESTNewsPrecision BioSciences GAAP EPS of -$0.26 misses by $0.05, revenue of $10.59M beats by $3.88MN/A
2023-03-09 00:47 ESTNewsPrecision BioSciences Q4 2022 Earnings PreviewN/A
2023-02-24 16:58 ESTNewsPrecision BioSciences chief scientific officer to step downN/A
2022-12-06 18:29 ESTNewsPrecision BioSciences: A Watch List Stock Going Into ASH PresentationN/A
2022-11-08 11:08 ESTNewsPrecision BioSciences GAAP EPS of -$0.22 beats by $0.05, revenue of $7.36M beats by $1.39MN/A
2022-09-02 15:02 ESTNewsPrecision BioSciences appoints chief business officer from within ranks, rejigs co-founders' rolesN/A
2022-08-17 00:06 ESTNewsPrecision BioSciences: CAR T Data Updates End Of 2022 And Plenty Of CashN/A
2022-08-09 01:33 ESTNewsPrecision BioSciences GAAP EPS of -$0.46 misses by $0.05, revenue of $3.82M misses by $1.29MN/A
2022-08-05 17:22 ESTNewsPrecision BioSciences Q2 2022 Earnings PreviewN/A
2022-06-28 02:47 ESTNewsPrecision BioSciences climbs 19% on heavy volume as equity offering closesN/A
2022-06-22 18:47 ESTNewsPrecision BioSciences stock soars premarket on R&D collaboration and license pact with NovartisN/A
2022-06-22 01:35 ESTNewsPrecision BioSciences to sell ~36M shares for gross proceeds of ~$50MN/A
2022-06-08 18:15 ESTNewsPrecision BioSciences provides promising early data on CAR T candidate for lymphomasN/A
2022-05-10 04:55 ESTNewsPrecision Bio: Another CAR-T Laggard With No Solid ProspectsN/A
2022-05-09 08:53 ESTNewsPrecision BioSciences GAAP EPS of -$0.46, revenue of $3.3MN/A
2022-03-15 22:19 ESTNewsPrecision BioSciences GAAP EPS of -$0.52 beats by $0.13, revenue of $115.53M beats by $2.42MN/A
2021-12-16 05:44 ESTNewsPrecision BioSciences (DTIL) Presents At 2021 ASH: Allogeneic CAR T Pipeline Update - SlideshowN/A
2021-11-11 04:55 ESTNewsPrecision BioSciences EPS beats by $0.41, beats on revenueN/A
2021-11-10 06:40 ESTNewsPrecision BioSciences Q3 2021 Earnings PreviewN/A
2021-10-08 06:37 ESTNewsPrecision BioSciences: Uniquely PositionedN/A
2021-09-27 16:22 ESTNewsPrecision BioSciences picks biotech industry veteran as CEON/A
2021-09-23 01:33 ESTNewsFIXX, DTIL, EAR and SYBX among after hours moversN/A
2021-09-09 23:52 ESTNewsPrecision Bio inks licensing deal for ARCUS-based gene editing therapiesN/A
2021-09-02 18:14 ESTNewsPrecision Bio inks licensing deal with Tiziana Life for foralumab in cancerN/A
2021-08-28 03:19 ESTNewsPrecision BioSciences: The Right Profile To ProgressN/A
2021-08-12 16:00 ESTNewsPrecision BioSciences EPS beats by $0.79, beats on revenueN/A
2021-07-21 06:03 ESTNewsPrecision BioSciences up ~7% following ASCO presentation announcementN/A
2021-07-21 05:57 ESTNewsPrecision BioSciences picks internal candidate for CFON/A
2021-07-21 05:47 ESTNewsPrecision Bio's PBCAR0191 shows potential as a therapy in non-hodgkin lymphomaN/A
2021-07-21 05:45 ESTNewsPrecision Bio's chief operating officer resignsN/A
2021-07-21 05:22 ESTNewsPrecision BioSciences (DTIL) PBCAR0191 CD19 Virtual Update PresentationN/A
2021-07-21 05:19 ESTNewsDosing underway in Precision Bio, SpringWorks Phase 1/2a PBCAR269A/nirogacestat combo trialN/A
2021-07-21 05:14 ESTNewsDosing underway in Precision Bio's early-stage PBCAR19B study in non-hodgkin lymphomaN/A
2021-04-15 18:40 ESTNewsPrecision Biosciences reacquires global rights to allogeneic CAR T programsN/A
2021-04-15 18:40 ESTNewsPrecision BioSciences appoints new CMON/A
2021-03-26 07:58 ESTNewsThe Prognosis For Precision BioSciencesN/A
2021-03-19 04:49 ESTEarnings EstimateAn EPS average of -$2.00 is estimated for the 2022 year.Sell
2021-03-19 04:49 ESTEarnings EstimateAn EPS average of -$0.51 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-19 04:49 ESTAnalyst RatingThe Analyst Target Price has increased from $18.13 to $18.25.Buy
2021-03-14 13:39 ESTNewsPrecision BioSciences: New Gene Editing Company With Major DealsN/A
2021-03-02 11:32 ESTAnalyst RatingThe Analyst Target Price has increased from $16.86 to $18.13.Buy
2021-03-01 11:27 ESTAnalyst RatingThe Analyst Target Price has increased from $16.14 to $16.86.Buy
2021-02-19 08:40 ESTNewsPrecision Bio announces peer-reviewed data supporting gene editing platformN/A
2021-02-01 07:31 ESTAnalyst RatingThe Analyst Target Price has increased from $15.57 to $16.14.Buy

About Precision BioSciences, Inc (DTIL):

Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome-editing platform to cure cancers and genetic disorders. The Therapeutic segment develops allogeneic CAR T immunotherapy that recognizes and kills cancer cells; and engages in the in vivo gene correction activities. This segment develops PBCAR0191, which is in Phase 1/2a clinical trial, an allogeneic CAR T cell therapy targeting the tumor target CD19 for acute lymphoblastic leukemia and non-hodgkin lymphoma; and PBCAR20A, an allogeneic anti-CD20 CAR T for the treatment NHL, chronic lymphocytic leukemia, and small lymphocytic lymphoma, as well as developing PBCAR269A, an allogeneic anti-BCMA CAR T cell product candidate for the treatment of R/R multiple myeloma. The Food segment develops food and nutrition products. The company has a development and commercial license agreement with Shire Plc for research and development of individual T cell modifications; and a collaboration agreement with Gilead Sciences, Inc. to co-develop a product candidate to cure chronic Hepatitis B infection. Precision BioSciences, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

DTIL Quotes by TradingView

See Advanced Chart

General

  • Name Precision BioSciences, Inc
  • Symbol DTIL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 223
  • Fiscal Year EndDecember
  • IPO Date2019-03-28
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.precisionbiosciences.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 27.13
  • Price/Book (Most Recent Quarter) 10.17
  • Enterprise Value Revenue 25.31
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Current Year EPS Estimate -$1.89
  • Next Year EPS Estimate -$2.00
  • Next Quarter EPS Estimate -$0.56
  • Operating Margin -493%
  • Return on Assets -32%
  • Return on Equity -97%
  • Revenue 21.96 million
  • Earnings Per Share -$3.12
  • Revenue Per Share $0.43
  • Gross Profit 22.24 million
  • Quarterly Earnings Growth 51.3%
View More

Highlights

  • Market Capitalization 599.55 million
  • EBITDA -66426000
  • PE Ratio -1.21
  • Analyst Target Price $18.25
  • Book Value Per Share $1.22
View More

Share Statistics

  • Shares Outstanding 56.24 million
  • Shares Float 43.22 million
  • % Held by Insiders 1185%
  • % Held by Institutions 50.24%
  • Shares Short 3.39 million
  • Shares Short Prior Month 3.36 million
  • Short Ratio 3.25
  • Short % of Float 7%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $16.6
  • 52 Week Low $4.55
  • 50 Day Moving Average 12.34
  • 200 Day Moving Average 9.17
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Precision BioSciences, Inc (DTIL) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Precision BioSciences, Inc (DTIL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31-$0.44-$0.11-300%
2020-09-302020-11-10$N/A-$0.50-$0.6826.21%
2020-06-302020-08-13$N/A-$0.63-$0.61-3.5%
2020-03-312020-05-15$7 million-$0.52-$0.532.49%
2019-12-312020-03-10$6.52 million-$0.36-$0.5636.17%
2019-09-302019-11-12$4.87 million-$0.41-$0.459.39%
2019-06-302019-08-14$5.39 million-$0.33-$0.4323.83%
2019-03-312019-04-29$5.46 million-$0.38-$0.392.69%

Precision BioSciences, Inc (DTIL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Precision BioSciences, Inc (DTIL) Chart:

Precision BioSciences, Inc (DTIL) News:

Below you will find a list of latest news for Precision BioSciences, Inc (DTIL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Precision BioSciences, Inc (DTIL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-06-212.50.05CALL5 1000TRUE00
2024-06-2150CALL0 00TRUE00
2024-06-217.50.05CALL0 10TRUE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 00FALSE00
2024-06-217.50PUT0 00FALSE00
2024-09-202.50.05CALL15 890TRUE00
2024-09-2050CALL0 00TRUE00
2024-09-207.50CALL0 00TRUE00
2024-09-202.50PUT0 00FALSE00
2024-09-2050PUT0 00FALSE00
2024-09-207.50PUT0 00FALSE00

Latest DTIL Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$1.205
Jun 13, 2022 7:59 PM EST1$1.205
Jun 13, 2022 7:59 PM EST7$1.205
Jun 13, 2022 7:59 PM EST92$1.205
Jun 13, 2022 7:59 PM EST100$1.205

Precision BioSciences, Inc (DTIL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020030837/0001564590-20-030837-index.htm
2018-11-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1357874/000000000018035523/0000000000-18-035523-index.htm
2019-02-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1357874/000000000019002975/0000000000-19-002975-index.htm
2019-03-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1357874/000000000019004011/0000000000-19-004011-index.htm
2019-03-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1357874/000000000019004946/0000000000-19-004946-index.htm
2020-06-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1357874/000000000020005101/0000000000-20-005101-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000031506619001465/0000315066-19-001465-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000031506619001467/0000315066-19-001467-index.htm
2019-04-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1357874/000031506619001468/0000315066-19-001468-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1357874/000031506620001151/0000315066-20-001151-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1357874/000083423720008262/0000834237-20-008262-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1357874/000083423720009121/0000834237-20-009121-index.htm
2020-06-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1357874/000090514820000666/0000905148-20-000666-index.htm
2020-06-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1357874/000090514820000719/0000905148-20-000719-index.htm
2020-07-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1357874/000090514820000793/0000905148-20-000793-index.htm
2018-10-19DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1357874/000095012318010005/0000950123-18-010005-index.htm
2018-12-28DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1357874/000095012318012547/0000950123-18-012547-index.htm
2018-12-28DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1357874/000095012318012548/0000950123-18-012548-index.htm
2019-02-21DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1357874/000095012319002440/0000950123-19-002440-index.htm
2019-02-21DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1357874/000095012319002442/0000950123-19-002442-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000101297519000251/0001012975-19-000251-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000101297519000254/0001012975-19-000254-index.htm
2020-03-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1357874/000114036120007099/0001140361-20-007099-index.htm
2020-03-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1357874/000114036120007101/0001140361-20-007101-index.htm
2019-03-01S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1357874/000119312519061192/0001193125-19-061192-index.htm
2019-03-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1357874/000119312519069462/0001193125-19-069462-index.htm
2019-03-13S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1357874/000119312519073065/0001193125-19-073065-index.htm
2019-03-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1357874/000119312519073220/0001193125-19-073220-index.htm
2019-03-18S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1357874/000119312519077399/0001193125-19-077399-index.htm
2019-03-198-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1357874/000119312519079674/0001193125-19-079674-index.htm
2019-03-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1357874/000119312519085243/0001193125-19-085243-index.htm
2019-03-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1357874/000119312519085252/0001193125-19-085252-index.htm
2019-03-28424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1357874/000119312519090666/0001193125-19-090666-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000119312519094641/0001193125-19-094641-index.htm
2019-04-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1357874/000119312519094734/0001193125-19-094734-index.htm
2019-04-09SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1357874/000119312519101787/0001193125-19-101787-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021472/0001209191-19-021472-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021474/0001209191-19-021474-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021475/0001209191-19-021475-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021476/0001209191-19-021476-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021477/0001209191-19-021477-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021478/0001209191-19-021478-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021479/0001209191-19-021479-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021480/0001209191-19-021480-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021481/0001209191-19-021481-index.htm
2019-03-293/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021847/0001209191-19-021847-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021848/0001209191-19-021848-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119021849/0001209191-19-021849-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119022658/0001209191-19-022658-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119022659/0001209191-19-022659-index.htm
2019-04-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119023673/0001209191-19-023673-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119036286/0001209191-19-036286-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119036287/0001209191-19-036287-index.htm
2019-06-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119037016/0001209191-19-037016-index.htm
2019-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119041388/0001209191-19-041388-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119049251/0001209191-19-049251-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119050699/0001209191-19-050699-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119050701/0001209191-19-050701-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119050702/0001209191-19-050702-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119050705/0001209191-19-050705-index.htm
2019-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119050706/0001209191-19-050706-index.htm
2019-10-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119052774/0001209191-19-052774-index.htm
2019-11-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119056251/0001209191-19-056251-index.htm
2019-11-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119056253/0001209191-19-056253-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919119061581/0001209191-19-061581-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120002445/0001209191-20-002445-index.htm
2020-03-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120018521/0001209191-20-018521-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120018527/0001209191-20-018527-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120024509/0001209191-20-024509-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120029688/0001209191-20-029688-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120029690/0001209191-20-029690-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120029691/0001209191-20-029691-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120030319/0001209191-20-030319-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120035568/0001209191-20-035568-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120035569/0001209191-20-035569-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120035570/0001209191-20-035570-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120035584/0001209191-20-035584-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120035586/0001209191-20-035586-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120035589/0001209191-20-035589-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120035591/0001209191-20-035591-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000120919120037218/0001209191-20-037218-index.htm
2019-03-25CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1357874/000135445719000143/0001354457-19-000143-index.htm
2015-05-12DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000135787415000003/0001357874-15-000003-index.htm
2018-06-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000135787418000001/0001357874-18-000001-index.htm
2019-03-15DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1357874/000135787419000001/0001357874-19-000001-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1357874/000142284920000051/0001422849-20-000051-index.htm
2019-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1357874/000156459019013706/0001564590-19-013706-index.htm
2019-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019013748/0001564590-19-013748-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019019846/0001564590-19-019846-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019021969/0001564590-19-021969-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1357874/000156459019032150/0001564590-19-032150-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019032155/0001564590-19-032155-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019035166/0001564590-19-035166-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019036138/0001564590-19-036138-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019042376/0001564590-19-042376-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1357874/000156459019042519/0001564590-19-042519-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019042540/0001564590-19-042540-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459019043094/0001564590-19-043094-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020001133/0001564590-20-001133-index.htm
2020-01-158-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020001153/0001564590-20-001153-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020003581/0001564590-20-003581-index.htm
2020-02-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1357874/000156459020004855/0001564590-20-004855-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020009540/0001564590-20-009540-index.htm
2020-03-1010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1357874/000156459020009541/0001564590-20-009541-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020009873/0001564590-20-009873-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020010239/0001564590-20-010239-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020015378/0001564590-20-015378-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020025634/0001564590-20-025634-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1357874/000156459020025635/0001564590-20-025635-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020026010/0001564590-20-026010-index.htm
2020-06-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1357874/000156459020027905/0001564590-20-027905-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020027952/0001564590-20-027952-index.htm
2020-06-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1357874/000156459020028780/0001564590-20-028780-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020030837/0001564590-20-030837-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020031756/0001564590-20-031756-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020039796/0001564590-20-039796-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1357874/000156459020039797/0001564590-20-039797-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020043766/0001564590-20-043766-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020044044/0001564590-20-044044-index.htm
2020-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1357874/000156459020047275/0001564590-20-047275-index.htm
2019-03-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1357874/999999999519000536/9999999995-19-000536-index.htm
2020-06-11EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1357874/999999999520001405/9999999995-20-001405-index.htm
2006-03-15REGDEXNotice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933]https://www.sec.gov/Archives/edgar/data/1357874/999999999706011667/9999999997-06-011667-index.htm
2019-03-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1357874/999999999719002050/9999999997-19-002050-index.htm

Precision BioSciences, Inc (DTIL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Precision BioSciences, Inc (DTIL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1185%
Institutional Ownership: 5024%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-06-10ABID ANSARIChief Financial OfficerBuy7,027.001.188,291.86103,645.00https://www.sec.gov/Archives/edgar/data/1357874/000120919119036287/0001209191-19-036287-index.htm
2019-06-10DAVID S. THOMSONChief Development OfficerBuy117,113.001.18138,193.34117,113.00https://www.sec.gov/Archives/edgar/data/1357874/000120919119036286/0001209191-19-036286-index.htm
2020-01-06ABID ANSARIChief Financial OfficerBuy17,566.001.2021,079.20121,211.00https://www.sec.gov/Archives/edgar/data/1357874/000120919120002445/0001209191-20-002445-index.htm
2020-01-06ABID ANSARIChief Financial OfficerBuy2,634.001.183,108.12123,845.00https://www.sec.gov/Archives/edgar/data/1357874/000120919120002445/0001209191-20-002445-index.htm
2020-05-15ABID ANSARIChief Financial OfficerBuy8,783.001.2010,539.60134,740.00https://www.sec.gov/Archives/edgar/data/1357874/000120919120030319/0001209191-20-030319-index.htm
2020-05-15ABID ANSARIChief Financial OfficerBuy878.001.181,036.04135,618.00https://www.sec.gov/Archives/edgar/data/1357874/000120919120030319/0001209191-20-030319-index.htm
2020-06-15ABID ANSARIChief Financial OfficerBuy8,783.001.2010,539.60144,401.00https://www.sec.gov/Archives/edgar/data/1357874/000120919120037218/0001209191-20-037218-index.htm
2019-04-03TONY DUNG LING YAODirectorBuy6,487.0015.42100,029.54158,003.00https://www.sec.gov/Archives/edgar/data/1357874/000120919119023673/0001209191-19-023673-index.htm
2019-09-23MATTHEW R. KANEPresident and CEOBuy10,000.001.1811,800.001,812,427.00https://www.sec.gov/Archives/edgar/data/1357874/000120919119050699/0001209191-19-050699-index.htm
2019-12-19Christopher HeeryChief Medical OfficerBuy2,235.0012.0826,998.802,485.00https://www.sec.gov/Archives/edgar/data/1357874/000120919119061581/0001209191-19-061581-index.htm
2019-12-19Christopher HeeryChief Medical OfficerBuy250.0012.093,022.50250.00https://www.sec.gov/Archives/edgar/data/1357874/000120919119061581/0001209191-19-061581-index.htm
2019-04-01FMR LLCInsiderBuy50,000.0016.00800,000.003,738,248.00https://www.sec.gov/Archives/edgar/data/1357874/000031506619001467/0000315066-19-001467-index.htm
2019-09-10DEREK JANTZChief Scientific OfficerBuy13,176.001.1815,547.683,858,346.00https://www.sec.gov/Archives/edgar/data/1357874/000120919119049251/0001209191-19-049251-index.htm
2020-04-14DEREK JANTZChief Scientific OfficerBuy4,392.001.185,182.563,862,738.00https://www.sec.gov/Archives/edgar/data/1357874/000120919120024509/0001209191-20-024509-index.htm
2019-04-01venBio Global Strategic Fund, L.P.DirectorBuy50,000.0016.00800,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1357874/000101297519000254/0001012975-19-000254-index.htm
2019-06-10ABID ANSARIChief Financial OfficerBuy96,618.001.20115,941.6096,618.00https://www.sec.gov/Archives/edgar/data/1357874/000120919119036287/0001209191-19-036287-index.htm